# The Effects of 3% Trehalose Ophthalmic Solution on Corneal Epithelial Barrier Function

> **NCT06655441** · PHASE4 · RECRUITING · sponsor: **Southern California College of Optometry at Marshall B. Ketchum University** · enrollment: 30 (estimated)

## Conditions studied

- Dry Eye Disease (DED)

## Interventions

- **DRUG:** 3% trehalose

## Key facts

- **NCT ID:** NCT06655441
- **Lead sponsor:** Southern California College of Optometry at Marshall B. Ketchum University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-03-01
- **Primary completion:** 2026-12
- **Final completion:** 2027-04
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-05-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06655441

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06655441, "The Effects of 3% Trehalose Ophthalmic Solution on Corneal Epithelial Barrier Function". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06655441. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*